Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Data 1 from A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer
  1. Home
  2. Publications
  3. Supplementary Data 1 from A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer

Supplementary Data 1 from A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer

Authors:
  • ASAlessandro D. Santin
    Alessandro D. Santin
  • DRDana M. Roque
    Dana M. Roque
  • ESEric R. Siegel
    Eric R. Siegel
  • VEVictoria M. Ettorre
    Victoria M. Ettorre
  • MGMichelle Greenman
    Michelle Greenman
  • BMBlair McNamara
    Blair McNamara
  • KPKatyayani Papatla
    Katyayani Papatla
  • AKAparna Kailasam
    Aparna Kailasam
  • NBNatalia Buza
    Natalia Buza
  • MCMitchell Clark
    Mitchell Clark
  • PHPei Hui
    Pei Hui
  • PDPeter Dottino
    Peter Dottino

Open Access
Publisher website
Google Scholar
  • 3 August 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.33143610
Abstract
No abstract available
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • GYNECOLOGICAL CANCERS
  • ENDOMETRIAL CANCER
  • IMMUNOTHERAPY
  • ANTIBODY IMMUNOTHERAPY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.